In IC-006 model, derived from a tumor bearing an ATM mutation, the combination is effective at two dose levels (1:0.01 and 0.5–0.005), while in IC-011 it is only effective at the higher dose level (1:0.01). This evidence concerns the gene ATM and neoplasm.